SCHEMBL4059832

SCHEMBL4059832

C[C@@H](NC(=O)c1ncc2cccnc2c1O)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.60
FEN1 P39748 1/20 0.50
SLC2A1 P11166 1/20 0.49
MAPK8 P45983 1/20 0.48
CLK1 P49759 2/20 0.47
NPC1 O15118 4/20 0.46
HSP90AA1 P07900 4/20 0.46
RAB9A P51151 4/20 0.46
ALDH1A1 P00352 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
KMT2A Q03164 2/20 0.46
LMNA P02545 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46
HSD17B10 Q99714 1/20 0.46
PAX8 Q06710 3/20 0.46
MAPK1 P28482 2/20 0.44
ROCK2 O75116 1/20 0.44
RPS6KA5 O75582 1/20 0.44
MAP4K4 O95819 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4065733 1.00 MAOA (0.60) MAOAFEN1SLC2A1MAPK8CLK1
SCHEMBL6492038 0.85 ELANE (0.53) MAOAFEN1SLC2A1NPC1HSP90AA1
SCHEMBL6500953 0.85 ELANE (0.53) MAOAFEN1SLC2A1NPC1HSP90AA1
SCHEMBL13849025 0.85 ELANE (0.54) MAOAFEN1SLC2A1NPC1HSP90AA1
SCHEMBL13848758 0.85 ELANE (0.54) MAOAFEN1SLC2A1NPC1HSP90AA1
SCHEMBL4060889 0.83 FEN1 (0.48) MAOAFEN1SLC2A1NPC1HSP90AA1
SCHEMBL2143913 0.81 EGLN1 (0.63) SLC2A1MAPK8NPC1HSP90AA1RAB9A
SCHEMBL2143917 0.81 EGLN1 (0.63) SLC2A1MAPK8NPC1HSP90AA1RAB9A
SCHEMBL4060413 0.81 FEN1 (0.47) FEN1SLC2A1NPC1HSP90AA1RAB9A
SCHEMBL4063678 0.81 ROCK1 (0.48) MAOAFEN1SLC2A1NPC1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6921759-B2 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK & CO., INC. (US) 2005-07-26 US claimed
US-20030055071-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK SHARP & DOHME CORP. 2003-03-20 US claimed
EP-1326865-B1 AZA- AND POLYAZA-NAPHTHALENYL CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2009-05-06 EP disclosed
EP-1326865-B1 AZA- AND POLYAZA-NAPHTHALENYL CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2009-05-06 EP disclosed
US-20050176718-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors ANTHONY NEVILLE J (US) 2005-08-11 US disclosed
US-6921759-B2 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK & CO., INC. (US) 2005-07-26 US disclosed
US-20030055071-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK SHARP & DOHME CORP. 2003-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055071-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors POLI, DUT, NAAA MAOA 711/4885FEN1 500/4885SLC2A1 4651/4885
US-20050176718-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors POLI, DUT, NAAA MAOA 711/4885FEN1 500/4885SLC2A1 4651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.